Brunner Eric J, Kivimäki Mika, Witte Daniel R, Lawlor Debbie A, Davey Smith George, Cooper Jackie A, Miller Michelle, Lowe Gordon D O, Rumley Ann, Casas Juan P, Shah Tina, Humphries Steve E, Hingorani Aroon D, Marmot Michael G, Timpson Nicholas J, Kumari Meena
Department of Epidemiology and Public Health, Royal Free and University College London Medical School, London, United Kingdom.
PLoS Med. 2008 Aug 12;5(8):e155. doi: 10.1371/journal.pmed.0050155.
Raised C-reactive protein (CRP) is a risk factor for type 2 diabetes. According to the Mendelian randomization method, the association is likely to be causal if genetic variants that affect CRP level are associated with markers of diabetes development and diabetes. Our objective was to examine the nature of the association between CRP phenotype and diabetes development using CRP haplotypes as instrumental variables.
We genotyped three tagging SNPs (CRP + 2302G > A; CRP + 1444T > C; CRP + 4899T > G) in the CRP gene and measured serum CRP in 5,274 men and women at mean ages 49 and 61 y (Whitehall II Study). Homeostasis model assessment-insulin resistance (HOMA-IR) and hemoglobin A1c (HbA1c) were measured at age 61 y. Diabetes was ascertained by glucose tolerance test and self-report. Common major haplotypes were strongly associated with serum CRP levels, but unrelated to obesity, blood pressure, and socioeconomic position, which may confound the association between CRP and diabetes risk. Serum CRP was associated with these potential confounding factors. After adjustment for age and sex, baseline serum CRP was associated with incident diabetes (hazard ratio = 1.39 [95% confidence interval 1.29-1.51], HOMA-IR, and HbA1c, but the associations were considerably attenuated on adjustment for potential confounding factors. In contrast, CRP haplotypes were not associated with HOMA-IR or HbA1c (p = 0.52-0.92). The associations of CRP with HOMA-IR and HbA1c were all null when examined using instrumental variables analysis, with genetic variants as the instrument for serum CRP. Instrumental variables estimates differed from the directly observed associations (p = 0.007-0.11). Pooled analysis of CRP haplotypes and diabetes in Whitehall II and Northwick Park Heart Study II produced null findings (p = 0.25-0.88). Analyses based on the Wellcome Trust Case Control Consortium (1,923 diabetes cases, 2,932 controls) using three SNPs in tight linkage disequilibrium with our tagging SNPs also demonstrated null associations.
Observed associations between serum CRP and insulin resistance, glycemia, and diabetes are likely to be noncausal. Inflammation may play a causal role via upstream effectors rather than the downstream marker CRP.
C反应蛋白(CRP)升高是2型糖尿病的一个风险因素。根据孟德尔随机化方法,如果影响CRP水平的基因变异与糖尿病发生的标志物及糖尿病相关,那么这种关联很可能是因果关系。我们的目的是使用CRP单倍型作为工具变量来研究CRP表型与糖尿病发生之间关联的性质。
我们对CRP基因中的三个标签单核苷酸多态性(CRP + 2302G>A;CRP + 1444T>C;CRP + 4899T>G)进行了基因分型,并在平均年龄为49岁和61岁的5274名男性和女性中测量了血清CRP(怀特霍尔二期研究)。在61岁时测量了稳态模型评估-胰岛素抵抗(HOMA-IR)和糖化血红蛋白(HbA1c)。通过葡萄糖耐量试验和自我报告确定糖尿病。常见的主要单倍型与血清CRP水平密切相关,但与肥胖、血压和社会经济地位无关,而这些因素可能会混淆CRP与糖尿病风险之间的关联。血清CRP与这些潜在的混杂因素相关。在调整年龄和性别后,基线血清CRP与新发糖尿病(风险比=1.39[95%置信区间1.29 - 1.51])、HOMA-IR和HbA1c相关,但在调整潜在混杂因素后,这些关联明显减弱。相比之下,CRP单倍型与HOMA-IR或HbA1c无关(p = 0.52 - 0.92)。当使用工具变量分析,以基因变异作为血清CRP的工具时,CRP与HOMA-IR和HbA1c的关联均为零。工具变量估计值与直接观察到的关联不同(p = 0.007 - 0.11)。对怀特霍尔二期研究和诺斯威克公园心脏研究二期中CRP单倍型与糖尿病的汇总分析结果为阴性(p = 0.25 -